Top

Published in:

01-08-2006

Phyllodes Tumor of the Breast: The Challenge Persists

Authors: Shih-Ping Cheng, MD, Yuan-Ching Chang, MD, Tsang-Pai Liu, MD, Jie-Jen Lee, MD, PhD, Chi-Yuan Tzen, MD, Chien-Liang Liu, MD

Published in: World Journal of Surgery | Issue 8/2006

Abstract

Introduction

Phyllodes tumors of the breast are uncommon, and it is difficult to predict biologic behavior based on clinicopathologic features. Despite the wealth of data on the factors to predict recurrence, little is known about the impact of treatment refinements. This study seeks to define changes in patient characteristics, histopathologic parameters, and outcome between the two periods before and after the care of patients with breast diseases was centralized to a breast specialty.

Methods

The records of 182 patients with phyllodes tumors managed surgically were reviewed. Patients treated from 1985 to 1996 (n = 81) were compared with those seen from 1997 to 2004 (n = 101).

Results

The analysis of the two treatment periods revealed that there was a decrease in tumor size at diagnosis, from 7.7 cm during the earlier period to 4.6 cm during the recent period (P = 0.003). The patients undergoing breast-conserving surgery were significantly increased during the recent period. In contrast, pathologic features and local recurrence rates remained unchanged during the study period. Multivariate analysis revealed that positive surgical margin was the only independent predictor of recurrence, with an increased hazard of 8.0. Overall, upgrading to the next grade was observed in 16% of recurrences.

Conclusions

Breast-conserving surgery with clear margins is the current treatment of choice for phyllodes tumors, but this strategy does not further reduce local recurrence effectively. Optimal management continues to be a challenge.

World Health Organization. Histological typing of breast tumors. Tumori 1982;68:181–198

Treves N. A study of cystosarcoma phyllodes. Ann NY Acad Sci 1964;114:922–936CrossRef

Vorherr H, Vorherr UF, Kutvirt DM, et al. Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival. Arch Gynecol 1985;236:173–181PubMedCrossRef

Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J 2001;77:428–435PubMedCrossRef

Khan SA, Badve S. Phyllodes tumors of the breast. Curr Treat Options Oncol 2001;2:139–147PubMed

Azzopardi JG. Problems in breast pathology. In Bennington J, editor, Major Progress in Pathology. Philadelphia, Saunders, 1979;346–365

Kuijper A, Buerger H, Simon R, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol 2002;197:575–581PubMedCrossRef

Kuijper A, van der Groep P, van der Wall E, et al. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast. Breast Cancer Res 2005;7:R808–R818PubMedCrossRef

Sawyer EJ, Hanby AM, Rowan AJ, et al. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J Pathol 2002;196:437–444PubMedCrossRef

10.

Grimes MM. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol 1992;5:232–239PubMed

11.

Hawkins RE, Schofield JB, Fisher C, et al. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes. Cancer 1992;69:141–147PubMedCrossRef

12.

Kleer CG, Giordano TJ, Braun T, et al. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 2001;14:185–190PubMedCrossRef

13.

Hajdu SI, Espinosa MH, Robbins GF. Recurrent cystosarcoma phyllodes: a clinicopathologic study of 32 cases. Cancer 1976;38:1402–1406PubMedCrossRef

14.

Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 1978;41:1974–1983PubMedCrossRef

15.

Salvadori B, Cusumano F, Del Bo R, et al. Surgical treatment of phyllodes tumors of the breast. Cancer 1989;63:2532–2536PubMedCrossRef

16.

Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes: analysis of ninety-four cases. Cancer 1967;20:2090–2099PubMedCrossRef

17.

Chen WH, Cheng SP, Tzen CY, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 2005;91:185–194PubMedCrossRef

18.

Ward RM, Evans HL. Cystosarcoma phyllodes: a clinicopathologic study of 26 cases. Cancer 1986;58:2282–2289PubMedCrossRef

19.

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481CrossRef

20.

Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1–39PubMed

21.

Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187–220

22.

Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 1993;71:3020–3024PubMedCrossRef

23.

Young JL Jr, Ward KC, Wingo PA, et al. The incidence of malignant non-carcinomas of the female breast. Cancer Causes Control 2004;15:313–319PubMedCrossRef

24.

Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes—Asian variations. Aust N Z J Surg 1988;58:301–305PubMed

25.

Alagaratnam TT, Wong J. Benign breast disorders in nonwestern populations Part I. Benign breast disorders in Chinese women. World J Surg 1989;13:743–745PubMedCrossRef

26.

Tan PH, Jayabaskar T, Chuah KL, et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol 2005;123:529–540PubMedCrossRef

27.

Blichert-Toft M, Hansen JP, Hansen OH, et al. Clinical course of cystosarcoma phyllodes related to histologic appearance. Surg Gynecol Obstet 1975;140:929–932PubMed

28.

Palmer ML, De Risi DC, Pelikan A, et al. Treatment options and recurrence potential for cystosarcoma phyllodes. Surg Gynecol Obstet 1990;170:193–196PubMed

29.

Rosen PP, Urban JA. Coexistent mammary carcinoma and cystosarcoma phyllodes. Breast 1975;1:9–15

30.

Grove A, Deibjerg Kristensen L. Intraductal carcinoma within a phyllodes tumor of the breast: a case report. Tumori 1986;72:187–190PubMed

31.

Knudsen PJ, Ostergaard J. Cystosarcoma phylloides with lobular and ductal carcinoma in situ. Arch Pathol Lab Med 1987;111:873–875PubMed

32.

Chaney AW, Pollack A, McNeese MD, et al. Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Invest 1998;6:264–267CrossRef

33.

Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma. Virchows Arch 1998;433:311–314PubMedCrossRef

34.

Kersting C, Kuijper A, Schmidt H, et al. Amplifications of the epidermal growth factor receptor gene (EGFR) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab Invest 2006;86:54–61PubMedCrossRef

Title: Phyllodes Tumor of the Breast: The Challenge Persists
Authors: Shih-Ping Cheng, MD
Yuan-Ching Chang, MD
Tsang-Pai Liu, MD
Jie-Jen Lee, MD, PhD
Chi-Yuan Tzen, MD
Chien-Liang Liu, MD
Publication date: 01-08-2006
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 8/2006
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-005-0786-2

At a glance: The STEP trials

Springer Medicine

Phyllodes Tumor of the Breast: The Challenge Persists

Abstract

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2006

Understanding the Peer Review Process

Gastric Cancer Surgery in Elderly Patients

Ethical Misconduct in Publishing: the Editors’ Perspective

Can Biliary Carcinoembryonic Antigen Identify Colorectal Cancer Patients with Occult Hepatic Metastases?

Hand-assisted Laparoscopic Splenectomy and Devascularization of the Upper Stomach in the Management of Gastric Varices

Impact of the Number and Extent of Positive Lymph Nodes in 200 Patients with Thoracic Esophageal Squamous Cell Carcinoma after Three-field Lymph Node Dissection